Adjuvant Chemo-Endocrine Therapy or Endocrine Therapy Alone for Postmenopausal Patients: Ludwig Studies III and IV-Reference-Cited by-同舟云学术

Adjuvant Chemo-Endocrine Therapy or Endocrine Therapy Alone for Postmenopausal Patients: Ludwig Studies III and IV

Published:1989 Issue: Volume: Page:153-162
ISSN:0080-0015
Container-title:Adjuvant Therapy of Primary Breast Cancer
language:
Short-container-title:

Author:

Goldhirsch A.,Gelber R. D.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-83337-3_22

Reference17 articles.

1. Baum M (1985) Nolvadex Adjuvant Trial Organisation: controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer: analysis at 6 years. Lancet I: 836–839

2. Bonadonna G, Rossi A, Valagussa T (1977) The CMF program for operable breast cancer with positive axillary nodes: update analysis of disease-free interval, site of relapse and drug tolerance. Cancer 39: 2904–2915

3. Cole MP (1975) A clinical trial of an artificial menopause in carcinoma of the breast. INSERM 55: 143–150

4. Fisher B, Sherman B, Rockette H, et al. (1979) L-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer. Cancer 44: 847–857

5. Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4: 1772–1779

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized adjuvant therapies: Lessons from the past;The Breast;2013-08

2. Does treatment at the time of locoregional failure of breast cancer alter prognosis?;Cancer Treatment Reviews;2001-04

3. Locoregionally recurrent breast cancer: incidence, risk factors and survival;Cancer Treatment Reviews;2001-04

4. Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: Still a question?;Cancer Treatment Reviews;1998-02

5. The role of hormonal therapy in breast cancer;Breast Cancer;1998-01